Hide Board Information

Show Board Information

Zoom Technologies ZTNO

Board Mod: Add me as mod

Asst Mods:

Last Post: 04/14/2020 12:43:21 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

Zoom Technologies (NASDAQ: ZTNO) Stock Message Board

1. ZTNO Company Profile

    

2. ZTNO Time & Sales

    

3. ZTNO Recent News

    

4. ZTNO Filings

    

5. ZTNO Financials

    

6. ZTNO Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	Zoom Users Turn to StrikeForces Privacy	riskreward007	04/14/2020 12:43:21 PM
6	$ZOOM 1900 SHARES TRADED AT $1.00 (1)	Go Green	03/25/2019 5:04:39 PM
5	Latest Zoom Technologies (ZOOM) Headlines Nasdaq	Stock_Tracker	03/13/2014 4:11:05 PM
4	ZOOM Stock Charts Last: +0.09 Sunday, March 2,	chartguy89	03/02/2014 12:38:59 AM
3	ZOOM Stock Charts Last: +0.03 Friday, February	chartguy89	02/28/2014 8:15:43 AM
2	The trading levels of Zoom Technologies, Inc.	riddock57	11/29/2013 1:27:43 PM
1	ZOOM DD is coming up shortly. Way undervalued	MASTERTRADER	02/20/2012 11:19:31 AM

Recent Articles

• Insights on the Upcoming Financial Street Forum in Beijing
• Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
• Investigation Announcement for Baxter International Investors
• Cytokinetics Investors: Secure Representation Before Deadline
• Jasper Therapeutics Investors: Important Class Action Deadline Ahead
• Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
• CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
• Ascletis Completes Enrollment in Phase IIa Study of ASC30.
• Innovations in Pancreatic Cancer Treatment with Satri-cel
• Cambodia's Techo International Airport: A Gateway to Growth
• Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
• Faraday Future's Vision: Accelerating Towards FX Super One Launch
• IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
• Clover Biopharmaceuticals Names Nicholas Jackson as President
• Dr. Luke Wainscoat Brings Expertise to The Brattle Group
• Kering and L'Oréal Unite to Transform Luxury Beauty Sector
• Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
• Kering Partners with L'Oréal to Transform Luxury Beauty Sector
• Alice Walton and Elon Musk: Giants of Wealth in 2025
• Clarins and V Magazine Host a Glamorous Golden Hour Event
• Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
• Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
• Exploring NB HASH and the Transformation of Wealth Today
• Kevin Hart's Journey From Investment Missteps to Business Success
• BlackRock's Strategic Shift: The Future of Investment in RWA
• Major Contract Termination Announced by Vantage Drilling
• Deadline Approaches for Dow Inc. Investors Amid Legal Action
• Important Update for Cepton, Inc. Investors on Class Action
• Target and Walmart Thrive Amid Collectible Card Sales Surge
• Snap Investors Urged to Consider Leading Legal Action
• Unlocking Wealth Potential: The RWA Revolution Explained
• Embracing Real-World Assets with NB HASH for Sustainable Growth
• Nutex Health Investors Can Join Class Action Against Company
• Potential Legal Action for Baxter International Investors
• Solidarity in Aviation: Airline Workers Support Controllers
• Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
• Promising Outcomes Unveiled from HARMONi-6 Clinical Study
• Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
• Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
• Promising Findings on Subcutaneous Amivantamab for Cancer
• Vivace Therapeutics Reports Promising Results for VT3989 Therapy
• iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
• Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
• New Breakthrough Data from Novartis on Prostate Cancer Treatment
• Transforming Assets: The Role of NB HASH in Digital Wealth
• The Future of Wealth: Bridging Real-World Assets with Blockchain
• Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
• Significant Phase 1a Trial Findings for Faridoxorubicin
• Major Developments in AI: Insights from Top Tech Executives
• Celebrating Five Years of Innovations at United Imaging's Hub